---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-003032"
form_type: "8-K"
ticker: "SCWO"
cik: "0000933972"
company_name: "374Water Inc."
filed_at: "2025-03-19T23:59:59+00:00"
generated_at: "2026-05-24T12:46:52.259114+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# 374Water fails Nasdaq independent director rule; cure period until March 9, 2026

## Summary
- Company notified Nasdaq on March 13, 2025 it lacks a majority of independent directors per Listing Rule 5605(b)(1).
- Cure period expires at earlier of next annual meeting or March 9, 2026; if meeting before Sept 8, 2025, then by Sept 8, 2025.
- Company plans to elect an additional independent director as soon as practicable to regain compliance.
- No immediate impact on listing or trading of SCWO common stock on Nasdaq Capital Market.
- 2025 Annual Meeting scheduled for June 11, 2025; stockholder proposals due by April 12, 2025.

## SEC filing metadata
- accession: 0001654954-25-003032
- form_type: 8-K
- ticker: SCWO
- cik: 0000933972
- company_name: 374Water Inc.
- filed_at: 2025-03-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/933972/000165495425003032/0001654954-25-003032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/933972/000165495425003032/scwo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-003032
- JSON: https://secwatch.observer/filing/0001654954-25-003032.json
- Plain text: https://secwatch.observer/filing/0001654954-25-003032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.